These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 15066868)
1. Neonate characteristics after maternal use of antidepressants in late pregnancy. Källén B Arch Pediatr Adolesc Med; 2004 Apr; 158(4):312-6. PubMed ID: 15066868 [TBL] [Abstract][Full Text] [Related]
2. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data. Singal D; Brownell M; Chateau D; Ruth C; Katz LY BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401 [TBL] [Abstract][Full Text] [Related]
3. Delivery outcome in relation to maternal use of some recently introduced antidepressants. Lennestål R; Källén B J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128 [TBL] [Abstract][Full Text] [Related]
4. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
10. Birth outcomes after prenatal exposure to antidepressant medication. Hendrick V; Smith LM; Suri R; Hwang S; Haynes D; Altshuler L Am J Obstet Gynecol; 2003 Mar; 188(3):812-5. PubMed ID: 12634662 [TBL] [Abstract][Full Text] [Related]
11. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202 [TBL] [Abstract][Full Text] [Related]
12. Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies. Hayes RM; Wu P; Shelton RC; Cooper WO; Dupont WD; Mitchel E; Hartert TV Am J Obstet Gynecol; 2012 Jul; 207(1):49.e1-9. PubMed ID: 22727349 [TBL] [Abstract][Full Text] [Related]
13. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Reis M; Källén B Psychol Med; 2010 Oct; 40(10):1723-33. PubMed ID: 20047705 [TBL] [Abstract][Full Text] [Related]
14. Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy. Nörby U; Forsberg L; Wide K; Sjörs G; Winbladh B; Källén K Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940758 [TBL] [Abstract][Full Text] [Related]
15. Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy. Källén B; Reis M J Clin Psychopharmacol; 2012 Oct; 32(5):608-14. PubMed ID: 22926593 [TBL] [Abstract][Full Text] [Related]
16. Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis. Vlenterie R; van Gelder MMHJ; Anderson HR; Andersson L; Broekman BFP; Dubnov-Raz G; El Marroun H; Ferreira E; Fransson E; van der Heijden FMMA; Holzman CB; Kim JJ; Khashan AS; Kirkwood BR; Kuijpers HJH; Lahti-Pulkkinen M; Mason D; Misra D; Niemi M; Nordeng HME; Peacock JL; Pickett KE; Prady SL; Premji SS; Räikkönen K; Rubertsson C; Sahingoz M; Shaikh K; Silver RK; Slaughter-Acey J; Soremekun S; Stein DJ; Sundström-Poromaa I; Sutter-Dallay AL; Tiemeier H; Uguz F; Varela P; Vrijkotte TGM; Winterfeld U; Zar HJ; Zervas IM; Prins JB; Pop-Purceleanu M; Roeleveld N Obstet Gynecol; 2021 Oct; 138(4):633-646. PubMed ID: 34623076 [TBL] [Abstract][Full Text] [Related]
17. Perinatal outcome following third trimester exposure to paroxetine. Costei AM; Kozer E; Ho T; Ito S; Koren G Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660 [TBL] [Abstract][Full Text] [Related]
19. Use of antidepressants during pregnancy and the risk of spontaneous abortion. Nakhai-Pour HR; Broy P; Bérard A CMAJ; 2010 Jul; 182(10):1031-7. PubMed ID: 20513781 [TBL] [Abstract][Full Text] [Related]
20. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Davis RL; Rubanowice D; McPhillips H; Raebel MA; Andrade SE; Smith D; Yood MU; Platt R; Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1086-94. PubMed ID: 17729378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]